8-K current report · filed Sep 8, 2026

ASP Isotopes Inc. (ASPI) 8-K Current Report: September 8, 2026

Item EX-99.1Item 7.01ASPI overview

Short answer

ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on September 8, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). Inaugural Capital Markets Day held in London on September 8, 2026, signaling expanded investor-outreach efforts.

ASP Isotopes Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Inaugural Capital Markets Day held in London on September 8, 2026, signaling expanded investor-outreach efforts
  • Press release and investor presentation likely outline ASP Isotopes’ strategic priorities, growth plans, and operating targets
  • Presentation available on the company’s Investor Relations website, providing investors with management’s current outlook and assumptions

Item EX-99.1 · Exhibit EX-99.1

  • Capital Markets Day signals transition from development to early commercialization across nuclear medicine, helium, LNG, electronics and nuclear fuels
  • Revenue catalysts include Phase 1 liquid helium production, radiopharmacy growth and first commercial stable-isotope shipments over the next 12 months
  • Management targets more than $300 million EBITDA in 2031, a long-term non-GAAP goal dependent on substantial execution and commercialization
  • Proposed separate public listings for Quantum Leap Energy and Noble Africa could unlock business-level financing and valuation, but remain uncertain
  • Forward-looking plans face funding, regulatory, construction and transaction-completion risks, including uranium-enrichment approvals and Noble Africa’s reverse merger

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ASP Isotopes Inc. 8-K filings

Get the next ASPI 8-K as it lands

Follow ASPI for push alerts, or ask the research agent what this filing means.